Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clinton J. Thompson is active.

Publication


Featured researches published by Clinton J. Thompson.


Pediatric Diabetes | 2009

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Jeffrey L. Mahon; Jay M. Sosenko; Lisa Rafkin-Mervis; Heidi Krause-Steinrauf; John M. Lachin; Clinton J. Thompson; Polly J. Bingley; Ezio Bonifacio; Jerry P. Palmer; George S. Eisenbarth; Joseph I. Wolfsdorf; Jay S. Skyler

Objectives:  TrialNet’s goal to test preventions for type 1 diabetes has created an opportunity to gain new insights into the natural history of pre‐type 1 diabetes. The TrialNet Natural History Study (NHS) will assess the predictive value of existing and novel risk markers for type 1 diabetes and will find subjects for prevention trials.


Journal of Neurosurgery | 2014

An analysis of publication productivity for 1225 academic neurosurgeons and 99 departments in the United States

Nickalus R. Khan; Clinton J. Thompson; Douglas R. Taylor; Garrett T. Venable; R. Matthew Wham; L. Madison Michael; Paul Klimo

OBJECT Bibliometrics is defined as the study of statistical and mathematical methods used to quantitatively analyze scientific literature. The application of bibliometrics in neurosurgery is in its infancy. The authors calculate a number of publication productivity measures for almost all academic neurosurgeons and departments within the US. METHODS The h-index, g-index, m-quotient, and contemporary h-index (hc-index) were calculated for 1225 academic neurosurgeons in 99 (of 101) programs listed by the Accreditation Council for Graduate Medical Education in January 2013. Three currently available citation databases were used: Google Scholar, Scopus, and Web of Science. Bibliometric profiles were created for each surgeon. Comparisons based on academic rank (that is, chairperson, professor, associate, assistant, and instructor), sex, and subspecialties were performed. Departments were ranked based on the summation of individual faculty h-indices. Calculations were carried out from January to February 2013. RESULTS The median h-index, g-index, hc-index, and m-quotient were 11, 20, 8, and 0.62, respectively. All indices demonstrated a positive relationship with increasing academic rank (p < 0.001). The median h-index was 11 for males (n = 1144) and 8 for females (n = 81). The h-index, g-index and hc-index significantly varied by sex (p < 0.001). However, when corrected for academic rank, this difference was no longer significant. There was no difference in the m-quotient by sex. Neurosurgeons with subspecialties in functional/epilepsy, peripheral nerve, radiosurgery, neuro-oncology/skull base, and vascular have the highest median h-indices; general, pediatric, and spine neurosurgeons have the lowest median h-indices. By summing the manually calculated Scopus h-indices of all individuals within a department, the top 5 programs for publication productivity are University of California, San Francisco; Barrow Neurological Institute; Johns Hopkins University; University of Pittsburgh; and University of California, Los Angeles. CONCLUSIONS This study represents the most detailed publication analysis of academic neurosurgeons and their programs to date. The results for the metrics presented should be viewed as benchmarks for comparison purposes. It is our hope that organized neurosurgery will adopt and continue to refine bibliometric profiling of individuals and departments.


Journal of Neurosurgery | 2014

Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 7: Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis

Paul Klimo; Clinton J. Thompson; Lissa C. Baird; Ann Marie Flannery

OBJECT The objective of this systematic review and meta-analysis was to answer the following question: Are antibiotic-impregnated shunts (AISs) superior to standard shunts (SSs) at reducing the risk of shunt infection in pediatric patients with hydrocephalus? METHODS Both the US National Library of Medicine PubMed/MEDLINE database and the Cochrane Database of Systematic Reviews were queried using MeSH headings and key words relevant to AIS use in children. Abstracts were reviewed, after which studies meeting the inclusion criteria were selected. An evidentiary table was assembled summarizing the studies and the quality of their evidence (Classes I-III). A meta-analysis was conducted using a random-effects model to calculate a cumulative estimate of treatment effect using risk ratio (RR). Heterogeneity was assessed using the chi-square and I(2) statistics. Based on the quality of the literature and the result of the meta-analysis, a recommendation was rendered (Level I, II, or III). RESULTS Six studies, all Class III, met our inclusion criteria. All but one study focused on a retrospective cohort and all but one were conducted at a single institution. Four of the studies failed to demonstrate a lowered infection rate with the use of an AIS. However, when the data from individual studies were pooled together, the infection rate in the AIS group was 5.5% compared with 8.6% in the SS group. Using a random-effects model, the cumulative RR was 0.51 (95% CI 0.29-0.89, p < 0.001), indicating that a shunt infection was 1.96 times more likely in patients who received an SS. CONCLUSIONS We recommend AIS tubing because of the associated lower risk of shunt infection compared to the use of conventional silicone hardware (quality of evidence: Class III; strength of recommendation: Level III). RECOMMENDATION Antibiotic-impregnated shunt (AIS) tubing may be associated with a lower risk of shunt infection compared with conventional silicone hardware and thus is an option for children who require placement of a shunt. STRENGTH OF RECOMMENDATION Level III, unclear degree of clinical certainty.


Annals of Pharmacotherapy | 2006

Adherence and Persistence with Single-Dosage Form Extended-Release Niacin/Lovastatin Compared with Statins Alone or in Combination with Extended-Release Niacin:

Joanne LaFleur; Clinton J. Thompson; Vijay N. Joish; Scott L. Charland; Gary M. Oderda; Diana I. Brixner

Background: Lipid-lowering therapies have been shown to reduce cardiovascular events and mortality; patient cooperation with therapy varies. A fixed-dose combination product, extended-release niacin/lovastatin (ERNL), has been shown to be beneficial in lipid management; however, little is known regarding patient behavior with ERNL therapy. Objective: To evaluate patient adherence and persistence with ERNL, statin monotherapy (SM), extended-release niacin (ERN) monotherapy, and ERN plus a statin (ERN-S). Methods: Prescription claims for lipid-lowering therapies were obtained from a pharmacy benefits manager between 2002 and 2003. Claims for a total of 2389 patients were analyzed for adherence and persistence, using medication possession ratios (MPRs) and proportions of days covered (PDCs). Adherence and persistence were defined, respectively, as an MPR or PDC greater than or equal to 0.80. Logistic regression was conducted to detect differences among groups. Covariates included age, gender, copay, and number of lipid-lowering therapies, a surrogate for disease severity. Results: Average MPR scores were relatively high in all groups at 0.88, 0.81, 0.89, and 0.90 for ERNL, SM, ERN, and ERN-S, respectively. The adjusted odds ratio for adherence was lowest for SM (0.69), which was statistically significant compared with ERN-S (1.43), but not ERNL (1.00) or ERN (0.74). Persistence outcomes were poor in all groups. By the fourth quarter, patients receiving ERN-S (OR 1.31) had significantly greater persistence than those receiving ERN (OR 0.41) and SM (0.61), but not those receiving ERNL (OR 1.00). Conclusions: Managed care patients tended to be adherent to chronic lipid-lowering therapies, based on a mean MPR greater than 0.8. However, most patients failed to persist for at least 6 months.


Journal of Neurosurgery | 2014

Bibliometric evaluation of pediatric neurosurgery in North America

Paul Klimo; Garrett T. Venable; Nickalus R. Khan; Douglas R. Taylor; Brandon A. Shepherd; Clinton J. Thompson; Nathan R. Selden

OBJECT The application of bibliometric techniques to academic neurosurgery has been the focus of several recent publications. The authors provide here a detailed analysis of all active pediatric neurosurgeons in North America and their respective departments. METHODS Using Scopus and Google Scholar, a bibliometric profile for every known active pediatric neurosurgeon in North America was created using the following citation metrics: h-, contemporary h-, g-, and e-indices and the m-quotient. Various subgroups were compared. Departmental productivity from 2008 through 2013 was measured, and departments were ranked on the basis of cumulative h- and e-indices and the total number of publications and citations. Lorenz curves were created, and Gini coefficients were calculated for all departments with 4 or more members. RESULTS Three hundred twelve pediatric neurosurgeons (260 male, 52 female) were included for analysis. For the entire group, the median h-index, m-quotient, contemporary h-, g-, and e-indices, and the corrected g- and e-indices were 10, 0.59, 7, 18, 17, 1.14, and 1.01, respectively; the range for each index varied widely. Academic pediatric neurosurgeons associated with fellowship programs (compared with unassociated neurosurgeons), academic practitioners (compared with private practitioners), and men (compared with women) had superior measurements. There was no significant difference between American and Canadian pediatric neurosurgeons. The mean Gini coefficient for publications was 0.45 (range 0.18-0.70) and for citations was 0.53 (range 0.25-0.80). CONCLUSIONS This study represents the most exhaustive evaluation of academic productivity for pediatric neurosurgeons in North America to date. These results should serve as benchmarks for future studies.


Pediatric Diabetes | 2011

A comparison of the baseline metabolic profiles between Diabetes Prevention Trial‐Type 1 and TrialNet Natural History Study participants

Jay M. Sosenko; Jeffrey L. Mahon; Lisa E. Rafkin; John M. Lachin; Heidi Krause-Steinrauf; Jeffrey P. Krischer; David Cuthbertson; Jerry P. Palmer; Clinton J. Thompson; Carla J. Greenbaum; Jay S. Skyler

Sosenko JM, Mahon J, Rafkin L, Lachin JM, Krause‐Steinrauf H, Krischer JP, Cuthbertson D, Palmer JP, Thompson C, Greenbaum CJ, Skyler JS, the Diabetes Prevention Trial‐Type 1 and TrialNet Study Groups. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial‐Type 1 and TrialNet Natural History Study participants.


Aids Research and Treatment | 2014

Engagement with Care, Substance Use, and Adherence to Therapy in HIV/AIDS

Patrice K. Nicholas; Suzanne Willard; Clinton J. Thompson; Carol Dawson-Rose; Inge B. Corless; Dean Wantland; Elizabeth Sefcik; Kathleen M. Nokes; Kenn M. Kirksey; Mary Jane Hamilton; William L. Holzemer; Carmen J. Portillo; Marta Rivero Mendez; Linda Robinson; Maria Rosa; Susara Petronella Human; Yvette Cuca; Emily Huang; Mary Maryland; John Arudo; Lucille Sanzero Eller; Mark A. Stanton; Marykate Driscoll; Joachim Voss; Shahnaz Moezzi

Engagement with care for those living with HIV is aimed at establishing a strong relationship between patients and their health care provider and is often associated with greater adherence to therapy and treatment (Flickinger, Saha, Moore, and Beach, 2013). Substance use behaviors are linked with lower rates of engagement with care and medication adherence (Horvath, Carrico, Simoni, Boyer, Amico, and Petroli, 2013). This study is a secondary data analysis using a cross-sectional design from a larger randomized controlled trial (n = 775) that investigated the efficacy of a self-care symptom management manual for participants living with HIV. Participants were recruited from countries of Africa and the US. This study provides evidence that substance use is linked with lower self-reported engagement with care and adherence to therapy. Data on substance use and engagement are presented. Clinical implications of the study address the importance of utilizing health care system and policy factors to improve engagement with care.


Journal of Neurosurgery | 2015

Cervicomedullary tumors in children

Joseph H. McAbee; Joseph S. Modica; Clinton J. Thompson; Alberto Broniscer; Brent A. Orr; Asim F. Choudhri; Frederick A. Boop; Paul Klimo

OBJECT Cervicomedullary tumors (CMTs) represent a heterogeneous group of intrinsic neoplasms that are typically low grade and generally carry a good prognosis. This single-institution study was undertaken to document the outcomes and current treatment philosophy for these challenging neoplasms. METHODS The charts of all pediatric patients with CMTs who received treatment at St. Jude Childrens Research Hospital between January 1988 and May 2013 were retrospectively reviewed. Demographic, surgical, clinical, radiological, pathological, and survival data were collected. Treatment-free survival and overall survival were estimated, and predictors of recurrence were analyzed. RESULTS Thirty-one children (16 boys, 15 girls) with at least 12 months of follow-up data were identified. The median age at diagnosis was 6 years (range 7 months-17 years) and the median follow-up was 4.3 years. Low-grade tumors (Grade I or II) were present in 26 (84%) patients. Thirty patients underwent either a biopsy alone or resection, with the majority of patients undergoing biopsy only (n = 12, 39%) or subtotal resection (n = 14, 45%). Only 4 patients were treated solely with resection; 21 patients received radiotherapy alone or in combination with other treatments. Recurrent tumor developed in 14 children (45%) and 4 died as a result of their malignancy. A high-grade pathological type was the only independent variable that predicted recurrence. The 5- and 10-year treatment-free survival estimates are 64.7% and 45.3%, respectively. The 5- and 10-year overall survival estimate is 86.7%. CONCLUSIONS Children with CMTs typically have low-grade neoplasms and consequently long-term survival, but high risk of recurrence. Therapy should be directed at achieving local tumor control while preserving and even restoring neurological function.


Peritoneal Dialysis International | 2017

Adoption of Telehealth: Remote Biometric Monitoring Among Peritoneal Dialysis Patients in the United States.

Susie Q Lew; Neal Sikka; Clinton J. Thompson; Teena Cherian; Manya Magnus

We examined participant uptake and utilization of remote monitoring devices, and the relationship between remote biometric monitoring (RBM) of weight (Wt) and blood pressure (BP) with self-monitoring requirements. Participants on peritoneal dialysis (PD) (n = 269) participated in a Telehealth pilot study of which 253 used remote monitoring of BP and 255 for Wt. Blood pressure and Wt readings were transmitted in real time to a Telehealth call center, which were then forwarded to the PD nurses for real-time review. Uptake of RBM was substantial, with 89.7% accepting RBM, generating 74,266 BP and 52,880 Wt measurements over the study period. We found no significant correlates of RBM uptake with regard to gender, marital, educational, socio-economic or employment status, or baseline experience with computers; frequency of use of BP RBM by Black participants was less than non-Black participants, as was Wt RBM, and participants over 55 years old were more likely to use the Wt RBM than their younger counterparts. Having any review of the breach by a nurse was associated with reduced odds of a subsequent BP breach after adjusting for sex, age, and race. Remote biometric monitoring was associated with adherence to self-monitoring BP and Wt requirements associated with PD. Remote biometric monitoring was feasible, allowing for increased communication between patient and PD clinical staff with real-time patient data for providers to act on to potentially improve adherence and outcomes.


The Journal of Physician Assistant Education | 2003

Research: Why, What, and Worth

Clinton J. Thompson; Stephen C. Alder

The term “research” is almost as vague as it is pervasive. Research is everywhere: it is manifest as “original research” in reputable journals, a lot of clinicians seem to be engaged in it, and success and competency for many clinicians rely on their adept navigation through, and engagement in, research. The short answer to “Why must I research?” is analogous to the philosophical quandary, Why? and its one-word answer, Because. The long answer, however, is a contextual one. Adept research skills and an understanding of current developments in industry are needed to avoid obsolescence of clinical skills and knowledge and to maintain a familiarity with the accelerating use of technology and changing modes of treatment. Furthermore, as PAs are becoming more autonomous in their roles as clinicians, they must increasingly rely on their skills at dissecting and interpreting the research literature in order to remain current in their clinical knowledge. But staying abreast of research is a tall order. The quantity of articles spawned from various research endeavors is voluminous, to say the least. The National Library of Medicine’s on-line database, Medline, contains more than 11 million references, citations, and abstracts, from more than 4,600 biomedical journals. 2 Virtually all of these references were

Collaboration


Dive into the Clinton J. Thompson's collaboration.

Top Co-Authors

Avatar

Paul Klimo

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Frederick A. Boop

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Nickalus R. Khan

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Douglas R. Taylor

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Asim F. Choudhri

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Garrett T. Venable

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cody L. Nesvick

University of Tennessee Health Science Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge